BioMark Diagnostics (BUX.C), a Canadian biotech firm focused on developing its advanced-stage cancer detection business, released its year-end financial statement today. The company noted some important milestones it achieved…
BUX.C
29 June 2022
BioMark Diagnostics (BUX.C) – Three Minute Hits Video
Gaalen Engen- BUX.C
Today, Gaalen Engen, long-time Equity.Guru writer, lays out what he thinks of BioMark Diagnostics (BUX.C), a Canadian-based biotech firm developing leading-edge early-stage cancer detection tech. Enjoy!…
Battling cancer has always been about timing, catch it early enough and you are better positioned for victory. Unfortunately traditional diagnosis is dependent on the physical discovery of cancerous…